Diamyd Medical AB (FRA:DMN) Gross Profit : €-0.31 Mil (TTM As of Nov. 2024)

Diamyd Medical AB Gross Profit Chart

Diamyd Medical AB Annual Data
	Trend	Aug15	Aug16	Aug17	Aug18	Aug19	Aug20	Aug21	Aug22	Aug23	Aug24
Gross Profit		Get a 7-Day Free Trial					-0.40	-0.22	-0.38	-0.26	-0.31

Diamyd Medical AB Quarterly Data
	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24	Aug24	Nov24
Gross Profit	Get a 7-Day Free Trial															-0.10	-0.07	-0.08	-0.07	-0.09

Competitive Comparison of Diamyd Medical AB's Gross Profit

For the Biotechnology subindustry, Diamyd Medical AB's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Diamyd Medical AB's Gross Profit Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Diamyd Medical AB's Gross Profit distribution charts can be found below:

* The bar in red indicates where Diamyd Medical AB's Gross Profit falls into.

Diamyd Medical AB Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Diamyd Medical AB's Gross Profit for the fiscal year that ended in Aug. 2024 is calculated as

Diamyd Medical AB's Gross Profit for the quarter that ended in Nov. 2024 is calculated as

Gross Profit for the trailing twelve months (TTM) ended in Nov. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.31 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Diamyd Medical AB's Gross Margin % for the quarter that ended in Nov. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Diamyd Medical AB  (FRA:DMN) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Diamyd Medical AB had a gross margin of -4,600.00% for the quarter that ended in Nov. 2024 => No sustainable competitive advantage

Diamyd Medical AB Gross Profit Related Terms

Thank you for viewing the detailed overview of Diamyd Medical AB's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.

Diamyd Medical AB Business Description